Featured
Advertisement
Trending - Altmetric
-
EZH2 inhibitors promote β-like cell regeneration in young and adult type 1 diabetes donors
-
Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results
-
Neoantigens: promising targets for cancer therapy
-
Harnessing innate immune pathways for therapeutic advancement in cancer